Sign In
Free Newsletter
Shionogi to buy Jersey City pharma for $2.5B
The newly formed company holds the rights to Radicava – a treatment for ALS, also known as Lou Gehrig's disease.
BioNJ’s Hart on policy, AI and what’s next for NJ life sciences
NJBIZ continues the conversation with CEO Debbie Hart, who discusses tariffs, technology, manufacturing and the most exciting developments in the industry.
BioNJ’s Hart talks investment, innovation in NJ
Debbie Hart sits down with NJBIZ to discuss life sciences growth here, changing gubernatorial administrations, and highlight state initiatives and opportunities helping to serve patients.
US, UK finalize pharma pricing deal to boost innovation
The agreement raises United Kingdom payments for medicines, easing cost pressures domestically as well as strengthening United States life sciences investment.
NEST campus in Kenilworth begins multimillion-dollar renovation (photos)
Ownership will add 75,000 square feet of modernized amenity space at the sprawling life sciences and technology campus that previously served as Merck's headquarters.
9 NJ tech companies rank on Deloitte fastest-growing list
These Garden State-based businesses highlight rapid revenue growth in software, fintech and life sciences on this year's iteration.
Middlesex College opens aseptic lab with J&J support
With support from Johnson & Johnson and other industry partners, the simulation space trains students for biotech and biomanufacturing careers through NJBioFutures.
Merck to build $3B manufacturing facility in Virginia
The Rahway-headquartered company said the 400,000-square-foot center is expected to create 500 jobs and will strengthen nation's life sciences sector.
Ascendis Pharma nearly doubles Princeton office
The Denmark-based company, which focuses on endocrine disease treatments, can now accommodate more than 100 employees at the 22,040-square-foot space.
Coriell breaks ground on new life sciences campus in Camden
The city anchor began work that will create biotech jobs and expand New Jersey’s innovation ecosystem with the state's 12th SIC.
Bristol Myers Squibb to acquire Orbital for $1.5B
The deal expands the Lawrenceville-based biopharmaceutical company's RNA medicine and in vivo CAR T-cell therapy capabilities.
SciSafe opens new biostorage facility in East Brunswick
The expansion provides advanced sample management, cold chain logistics and support for biotech research.
